Good day, and thank you for standing by. Welcome to the Solesence, Inc. Common Stock third quarter 2025 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question and answer session. To participate, you will need to press star 11 on your telephone. You will then hear a message advising your hand is raised. To withdraw your question, simply press star 11 again. We ask that you please keep your questions to one and requeue if needed. Please note this conference is being recorded. During this call, management will make statements that include forward-looking statements within the meaning of the federal securities laws which are pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. This conference call may contain statements to reflect the company's current beliefs and a number of important factors could cause actual results for future periods to differ materially from those stated on this call. These important factors include, without limitation, a decision of the customer to cancel purchase order or supplies, agreement demand for any of the company's personal care ingredients, advanced materials, and formulated products, changes in development and distribution relationships, the impact of competitive products and technology, possible disruption in commercial activities occasioned by public health issues, terrorist activity, and armed conflict, and other risks indicated in the company's filings with the Securities and Exchange Commission. Except as required by federal securities laws, the company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, and other contingencies. I now hand the conference over to Kevin Carrington, President and Chief Executive Officer. Please go ahead, sir.

Thank you, operator. And thank you to all of our investors, teammates, and friends joining us today. We have a lot to cover, so we appreciate your time, patience, and attention. Today is a meaningful moment in the history of Solesence, Inc. Common Stock. This is my first opportunity to speak with you since stepping into the role of President and Chief Executive Officer. I am truly honored to take on this responsibility and energized by the incredible talent of our team, and the strong opportunities ahead to continue growing profitably with our brand partners. It is also a significant moment for another reason. Today marks Jess Jankowski's final earnings call as a member of the Solesence leadership team. Many of you know that Jess and I began this journey together in 2012 when he brought me in to help chart a new path forward. The conversations we had during that interview process about the business from a materials company into a product-focused organization became the foundation of what Solesence, Inc. Common Stock is today. Jess has been an exceptional partner to me and to all of us, working tirelessly to ensure we had the financial strength to grow, innovate, and establish ourselves as a leader in beauty innovation. With that, I'd like to turn it over to Jess for a few remarks. Jess?

Thanks, Kevin. Since this will be my final earnings call, I'd like to briefly touch on my time at Solesence, Inc. Common Stock and why now is the right time for Kevin to lead the company going forward. Over the past decade, Solesence, Inc. Common Stock has pioneered the skin health and mineral-based beauty industry, establishing more than 90 globally issued patents across four technology platforms. By collaborating with our brand partners, the use of mineral-based active ingredients in beauty products has become more widespread. Now we're seeing more and more brands infuse their products with SPF technology. We've grown at a CAGR of greater than 7x as compared to our addressable market in the skincare, color cosmetics, and sun care cosmetics areas. We have won eight awards for product and technology innovation so far and are sure to win more. Now we're the industry leader in this space. As I pass the torch to Kevin, we believe we can expand on this position for several reasons. First, the complexity and difficult logistics that go into creating these types of products mean that our industry has substantial barriers to entry that limit the number of potential competitors. Second, we possess a unique mix of expertise, best-in-class technology, and manufacturing capabilities that very few can match. Third, Solesence, Inc. Common Stock will maintain the same relentless commitment to scientific excellence and innovation that has always driven us. As I've reflected on my time here, I couldn't be more gratified by what we've accomplished. The transformation of Solesence, Inc. Common Stock is a testament to the hard work and dedication of our team. I'm grateful for having the opportunity to work alongside so many talented individuals. It has been no less than a privilege. This includes Kevin, with whom I've worked closely for over a decade. With his extensive industry experience, deep expertise, and vision, I'm confident that he is the right person to lead Solesence, Inc. Common Stock into this next exciting era of growth. I'll now pass the call to Kevin, who will provide a summary of the quarter as well as the vision and outlook for the company. Kevin?

Thank you, Jess, for your partnership. And, again, congratulations. Turning now to our work today. I've been honored to be in leadership positions with Solesence, Inc. Common Stock for over a decade, including leading the founding and development of our core consumer beauty, health, and wellness business, which has grown into the company we are today. While that journey and the accomplishments Jess covered have all been important achievements, and we should feel rewarded, our entire organization knows we have much work ahead of us. As evidenced by our third quarter results, 2025 represents the first quarter in almost two years where we did not have a year-over-year revenue increase. Admittedly, Q3 2024 was a record quarter for our company in both revenue and profitability and represented the level of profitability and performance we expect. So the comparison was going to be difficult. However, we remain confident in our ability both on a near-term and a longer-term basis to continue to grow at a multiple of the industry's growth rate and remain highly profitable while doing so. Our confidence is reinforced by the growth plans of our strategic brand partners. Without exception, each of them is expecting to outperform the market in the same manner as they have over the previous two years. Our products are important drivers for these companies' revenues, typically representing 30 to 60% of their business volume. So their success is our success. These brands are winning in the key retail segments where consumers want to buy beauty products, specifically at specialty beauty retailers and through TikTok and Amazon. Revenue growth combined with best-in-class profitability comes from the combination of the changes we've made in our leadership and our organization's structure. We believe three factors have hindered our ability to generate growth. These are, one, product…

Thank you, Kevin. Good morning, everyone. I'm pleased to be joining you on today's call. Revenue for the third quarter was $14.5 million, a decrease of 14% year-over-year amidst a general softening in the industry reflecting the shift in consumer behaviors. As Kevin mentioned earlier, last year's third quarter was a record quarter, creating a challenging comparable as our customers adjusted their inventory levels as compared to the third quarter of 2024. In the third quarter, our shift in open orders, which represent the total value of customer orders that we've either already shipped or are still awaiting fulfillment in 2025, is currently $64 million compared to $34 million in the third quarter of last year and $60 million in 2025. Gross profit in the third quarter was $3.4 million compared to $6.1 million in 2024. Gross margin was 23% compared to 36% for the same period last year. The decrease was related to manufacturing operating inefficiencies and facilities improvements. Operating expenses in the third quarter totaled $4.2 million compared to $2.9 million in 2024. The increase is due to increased employee-related costs, legal costs, allowance for credit loss, severance costs, and costs related to our uplifting to Nasdaq in 2025. During the third quarter, other income included an adjusted payment of $1.2 million relating to funds received from the US Department of the Treasury under the employee retention credit program, along with approximately $300,000 in interest received related to the delayed payment. The ERC is a refundable payroll tax credit made available under the CARES Act and subsequent legislation. Interest income included interest paid relating to this amount of about $200,000 in the third quarter of 2025. The ERC payments and related interest did not apply to 2024. Solesence, Inc. Common Stock reported a net loss of $1.1 million compared to net income of $3 million in 2024. Adjusted EBITDA for the quarter was a loss of $435,000 compared to adjusted EBITDA of $3.6 million for the third quarter of last year. As Kevin noted, we made significant improvements to our business operations that will enable us to grow and deliver the highest quality products to our brand partners more efficiently and from a greater cost position. That concludes our opening remarks. Operator, you may open the call for questions.

Thank you. And as a reminder, to ask a question, simply press 11 to get in the queue and wait for your name to be announced. To withdraw your question, press 11 again. One moment for our first question. And it comes from the line of Wayne Rohn. Please go ahead.

Congratulations, Jess. I hope your retirement goes well. I probably butt into you at Wrigley Field. But good luck, Kooga. Wayne. Oh, yeah. You won't butt into me at Wrigley Field. I'm very disappointed. This was supposed to be a better year. Are we making the same mistakes over and over and over again? And where do we get some optimism for the sales part bothers me a lot. What's the matter with that? And just mistakes we've made is not very comforting, and I'd like your response, Kevin.

Good morning, Wayne. You might bump into me at Wrigley Field, by the way. But thank you for your question. And we do take all of these very seriously. So let's start with the first question, which was are we making some of the mistakes? Same mistakes over and over? I can tell you, Wayne, that there are some areas that we have had a longer time to repair. Which is why we made some of the changes that we've made to the organization over the last quarter. So specifically around inventory management, that is an area that has taken us more time than we would like to repair. But with the changes that we've made, we're confident that we're on the right path to fixing that issue. Your other question was related to the revenue. And what's going on there. I think first, let's make sure we're clear, and we didn't talk about it. In our prepared remarks. But on a full-year basis, we're up $10 million over the prior year. So the trend for growth is strong. One of the things that has changed and is really related in part to consumer sentiment and our brand partners' desire to be conservative relative to their inventory levels is that they're not giving us the same lead time that they have in the past. And they're not stocking inventories at the same level that they had last year. So that had a material impact on a year-over-year basis between what we saw in 2024 in terms of revenue and what we saw in 2025. Rest assured again that we have and continue to expect to grow at the top line. So that is something that we're confident in. The final point is to make sure we're clear that, yes, we are taking the profit growth very seriously. It is an important part of the planning that we've done. And the adjustments that we've made in terms of structure, and the changes that we've made in terms of some of the other processes that we mentioned during our prepared remarks.

Thank you. And how come you waited so long to put out the third quarter? Because normally, you do first week. You know, get

Another good question, Wayne. You've got a new leadership team that wanted to make sure we did it right the first time.

Is the goal to me. Alright.

I'm sorry.

I said, there you go. That's a good idea. Thank you. So

that's it. That was the reason.

Thank you. And let's do look for do we have possibilities of greater sales reports?

For the fourth quarter this year. Our expectation on a full-year basis is that we will see an improvement over the prior year. So, yes, I think that in total, you'll see a positive revenue versus 2024. So we are staying on that trend, Wayne. So yes.

Thank you.

Thank you. Our next question comes from the line of Ronald Richards. Please proceed.

Can you hear me?

Yes, sir. We can hear you. Please proceed. Hi, Ron. Hi.

You know, I got a few questions. But I guess I'll start off with a really simple one. You know? It was a really simple mistake that led to your big lawsuit a couple of years ago. In a contract. Where there was one little sentence that somebody missed. Then this last quarter or two quarters ago, you had this $2 million error because of a screw-up on a new order. And this quarter, you know, it's really really simple. And you might think it isn't meaningful, but the announcement for this conference call referred to Central Daylight Time and Eastern Daylight Time. You know, all these things have a common point to them. Just the simple things, details are over. Is this gonna improve? Or are we gonna continue having a series of simple mistakes that cause the problems we're having?

Thanks, Ron, for the question. First, your first statement related to the lawsuit, I'm presuming you're referencing the BASF lawsuit. You know, we'll agree to disagree on that. That wasn't really driven by a contractual mistake or error. In fact, it was a decision. Let's just put it this way. The simplest way for us to put it is just commercial points of difference. And we did settle that in an amicable way with BASF and that has been an important part of quite honestly, our ability to continue to set scale the Solesence, Inc. Common Stock business. On the other two points, well taken. We certainly know that the details matter. It's an important part of our business. It's one of the things that we mentioned in our prepared remarks around product design. And making sure that we have the exacting specifications clearly understood and stated. So thank you for that comment. We are taking those things to heart, and it is an important part of what we're doing to improve the profit performance of the company.

Our next question comes from the line of Stefano Bollis. Please proceed.

Hello. Good morning, and congratulations, Kevin, for your new role. And thanks to Jess for having sailed the vessel during all these years up to this point. And what is going? Gonna Okay. My question is, the gross margin for this quarter is this the fact that it's not around or slightly above the 30% Is this because of this reorganization work that you mentioned initially? Or was there something else?

Yeah. Your question related to gross margin is just to be clear, Stefano, and hopefully, you can respond to this. You're asking is the cause of the lower gross margin, is that what you're referring to?

Yeah.

Okay. Yes. Yeah. So in part, the lower gross margins were related to the expenses with the consolidation that weren't able to be capitalized. But they were also related to the transition that we mentioned. So we have good performance on a year-over-year basis at the direct labor level. Where we actually decrease direct labor pretty significantly on a per-unit basis. And in total. But we are, as that transition was occurring to the newer structures, still had higher indirect expenses. That we are addressing as we go forward. So that was one of the big drags on the indirect or, excuse me, on the gross margin. And I think, you know, Laura had mentioned some of the benefits of the changes that we're making. Laura, would you wanna comment at all on us?

You know, in obviously, the short time I have been with the company, we have taken seriously the indirect cost and I feel very confident that we are making the changes and having the discussions that are necessary to improve our overall indirect costs. And I expect to see that improvement within the next few quarters. And actually sooner than that.

Thank you.

Our next question comes from the line of Tony Rubin. Please proceed.

Hi, good morning. This is a couple of questions. But following up on the first gentleman's question who asked about your sales and margin forecasting, you just said sales will be up in 2025. They're through the first three quarters already up $10 million, and as we're basically halfway through Q4, can you shed any light on what sales for the fourth quarter will look like? And what margins will look like as well as give us an outlook in some general sense as to 2026.

Good morning, Tony. So, yes, you're correct. The sales are up $10 million on a nine-month basis. As Laura indicated on a shift in open, and you remember that metric that we've been using, we're projecting around $64 million for the year, essentially. Which would put us up roughly $12 million on a full-year basis versus the prior year. We are working through the changes that we mentioned, and so we're very confident in improving the direct margin levels on a continuing basis. That work is well in hand and is yielding the results that we expected. The indirect margins or, excuse me, indirect costs, I should say, that are contributing to the gross profit level are going to be, as Laura mentioned, work over the next couple of quarters to improve that. So, as we improve that over the next couple of quarters, we'd expect the margins to normalize back to levels that we have seen say, a year ago. This quarter. So do anticipate doing that as we go through the next couple of quarters or so. In terms of a projection on 2026, we are because of the uncertainty that we're seeing from the marketplace and consumer sentiment, we're going to refrain from giving too much guidance there. Except to say that two things. One, we know that in general, most consumer markets are slowing down, and beauty is no exception to that. It is slowing. However, we're still confident that our growth rate will be a multiple of the industry's growth rate. So, we'll refrain from saying too much more than that at this point. Over the next coming weeks. We do plan on presenting our first investor presentation, Tony. And then that will give more guidance in terms of our expectations, not just for '26, but for the next few years beyond that. As well?

Our next question comes from Stefano Bollis. Please proceed.

On indirect cost. So just for future modeling, the level the run rate of the SG&A expenses is it going to stay on this $3 million that we have seen in the last two quarters? Or this is due to those one-off impacts that you mentioned, the uplisting and some credit losses allowances and so on.

Yeah. Could you repeat your question? We had a hard time hearing you at the beginning of your question.

Okay. The question is on the expected run rate of the SG&A expenses that from historical levels were at $2 million or below $2 million. And right. Last and this quarter, they are $3 million. Is this the new level or there was a lot of components that are one-off?

Yeah. I would say for planning purposes, we're operating in that zone on a going forward basis. I think that some additions to our leadership team are part of that, obviously. To help strengthen the organization and to improve our overall performance. We've obviously added Laura. We've also added a VP of HR. There's been some other support functions added in there as well. And, you know, generally, for the business as we're operating right now, we have a little higher legal fees than we've had historically. But it is something that we've given the nature of our business, we've gotta at least plan for that over the next few quarters.

There was also, Stefano, though, a significant hit for me. There was a $400,000. You have to take the expenses for severance at one time. So that will not repeat going forward. So you know, right there, that's 15% of that total is not coming back. And we also think that generally speaking, we are gonna have all of our doubtful accounts run through SG&A, not COGS. So we believe we are gonna have better experience in that going forward. So that's gonna mitigate some of the investments we're making on the other side. To do that.

Our next question comes from Tony Rubin. Please proceed.

Yeah. Hello. I just wanted to follow-up to your quest or to your response, Kevin, on margins. You indicated that you thought margins would get back to a level of a year ago. What is your expected or target 2026 margins? And given all these spends on capital, efficiency, measures, etcetera, etcetera, you still I think, no matter what number you say, are gonna be short of your COVID-era margins where you were you know, in that 40% range. And is that something that we will ever see again? As you mentioned, the company is in your words, or to paraphrase, a leader in making these you know, complex formulations that the market does want. And just kind of as a side follow-up, I guess, I'm trying to cram a lot in here. You mentioned that you will grow at multiples of the industry, but that the industry is growing is softening. And if you could clarify what exactly that means because that's it's pretty difficult to parse. That. Yep. So Thank you. I'm gonna

Thank you. Thank you, Tony. There were three very important there. And we'll try and make sure we answer them all. And I will say, to the team that's managing this call, if we fall short please let Tony requeue so I can answer that third question. But let's start at the top. On the margins. So our guidance at this point Tony, we're gonna refrain from giving too much guidance on 2026. We will be prepared to provide further guidance soon. But we absolutely expect that our goal is 30% is really the floor for our guidance. Not the ceiling. And so just that's that's all we're gonna be prepared to say today. At least on 2026. In terms of COVID-era margins, you know, one of the things we talked a lot about as a leadership team was what is the margins that we anticipate achieving. We view ourselves as a technology leader as you mentioned, and quite honestly, the investments that we make in IT that has translated into our growth reinforce that. All of the different patents that are unique in terms of a company our size and operating in such a focused market as we do in part of the in terms of being able to represent us as a technology company. So we expect to achieve margins in that 40 plus percent range. That is an objective for our business. We know that that won't be something we can do overnight. But at the very top of that list, we are doing a much better job at driving direct margin performance and, ultimately, with some improvements at the indirect level, we'll be able to improve overall gross margins as well. And I think the third question I'm looking at Laura. Don't remember. So

Don't remember the third week.

So, Tony, if you can read that for us? Yeah. Requeue and repeat, that would be helpful. Thank you.

Tony, your line is open.

I think you gave a flavor of what I was asking. Unfor I would hope for more specificity, and I would hope 30% would be considered a disaster, not even a floor. You know, with respect to that. I do applaud the company having an investor presentation presumably to get some institutional shareholdings and to articulate the story. As I'm sure you're aware, the stock has plunged in recent weeks, which, as I'm sure everybody on this call the management team especially is not happy with. So the ability to provide more clarity going forward certainly would be appreciated. And, frankly, the company has excelled at R&D has been good, degraded sales, but has continually failed in operation. So any measures that can really fix those issues and could instill confidence in the community I'm sure would be rewarded in spades and you know, to the benefit of all. So you know, good luck and godspeed, and thank you. Thank you, Tony. I think his last question that we all forgot was about the multiple of the market relative to how our growth was gonna be.

Yes. Thank you. Glad somebody's paying attention here.

Well, Jess, you could always have a job. It helped me not to answer so much. But thank you, Tony, for your comments. And you know, I do think that we will take that praise well that we've been excellent at R&D and good to great on the sales and marketing sides of the organization. We also accept the criticism that the company needs to improve in operations. And that's really a reflection of a lot of the changes that we've made and announced. It's also reflected in the type of recruiting that we've done over the last year and a half. In terms of bringing in really excellent people from top organizations that have been in the beauty and personal care industry. And understand what it takes to translate the products that we design into finished goods that are meeting or exceeding our profit expectations. In terms of the going forward and what's happening in the industry, so, generally, the industry is slowing down. I will say that one of the good parts of our focus is that the SPF-infused beauty areas where we operate are continuing to be strong. And they are growing faster generally than the industry. Our benefit has been over the past few years is that along with the growth of SPF-infused beauty, consumers' preference in that space has tended and trended toward mineral-based SPF-infused beauty. You combine that consumer preference with the growth in the industry, that means that generally, mineral-based SPF-infused beauty is gaining share against other types of approaches to providing SPF. That said, you then further, as you have already mentioned, Tony, our leadership around technology and enabling that technology, quite honestly, enables us to have preferential aesthetics in terms of transparency on skin, the lightness of the textures, the fullness of coverage when required or transfer skin-like appearance that our products can deliver all our preferences. And so that has helped us through having some great brand partners to really be able to grow at a multiple of the industry and we continue to expect through our investments in those brand partners to sustain that growth rate.

Our next question is from Ronald Richards. Please proceed.

I wanted to follow-up with my first question. I didn't really understand this ERC payment. Was that in this Q3, or was that in last year's Q3? I thought that you said it was in this year's Q3. Without that payment, would the financials have been $1.3 million worse?

Hi, Ron. Thank you for your question. The ERC payment was in this quarter of 2025. You are correct.

Man, that doesn't sound good. The total bottom line here.

It would have impacted, obviously, our bottom line for the third quarter. And ladies and gentlemen, this concludes our Q&A session. I will pass back to Kevin Carrington for concluding remarks.

Thank you, Carmen. Back in 2019 when the consumer products business was less than $2 million, that was the first time that our company used the phrase the future of sun care is the future of beauty. Looking forward, we believe that remains true. Consider that Sun Care is expected to be one of the fastest-growing segments in beauty over the next five years. Further, Mirror, we observed that the ongoing transition of daytime products to incorporate UV protection as a key benefit enabling longevity. Health, and wellness. Because of these market dynamics, our technological and product leadership and commitment to driving improvements in operations that will yield significantly improved profitability. We remain confident and committed to delivering best-in-class performance not just to consumers, but also to our shareholders. In the coming weeks, we will release our first investor presentation. This will help each of you further understand our confidence in our future and the returns that our business can deliver to our investors. Like longevity and health, our process to deliver these results is a journey. We appreciate all of you who will remain on this journey with us. As we believe like the prior five years, the next five years will yield dynamic returns for all our investors. Thank you, and have a great day. And happy holiday season to all of you.

And ladies and gentlemen, this concludes our conference. Thank you for participating. You may now disconnect.